As of 2025-07-16, the Relative Valuation of AnaptysBio Inc (ANAB) is (66.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.63 USD, the upside of AnaptysBio Inc based on Relative Valuation is -350.3%.
The range of the Relative Valuation is (65.57) - (62.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 13.1x | 11.1x |
| Forward P/E multiples | 13.7x - 19.8x | 16.8x |
| Fair Price | (65.57) - (62.70) | (66.65) |
| Upside | -346.2% - -335.5% | -350.3% |
| Date | P/E |
| 2025-07-11 | -5.47 |
| 2025-07-10 | -5.45 |
| 2025-07-09 | -5.38 |
| 2025-07-08 | -5.07 |
| 2025-07-07 | -4.90 |
| 2025-07-03 | -4.96 |
| 2025-07-02 | -4.99 |
| 2025-07-01 | -4.73 |
| 2025-06-30 | -4.64 |
| 2025-06-27 | -4.69 |
| 2025-06-26 | -4.88 |
| 2025-06-25 | -4.86 |
| 2025-06-24 | -4.87 |
| 2025-06-23 | -4.77 |
| 2025-06-20 | -4.84 |
| 2025-06-18 | -4.89 |
| 2025-06-17 | -4.98 |
| 2025-06-16 | -4.99 |
| 2025-06-13 | -4.87 |
| 2025-06-12 | -4.89 |
| 2025-06-11 | -4.93 |
| 2025-06-10 | -5.01 |
| 2025-06-09 | -4.84 |
| 2025-06-06 | -4.95 |
| 2025-06-05 | -4.42 |
| 2025-06-04 | -4.44 |
| 2025-06-03 | -4.91 |
| 2025-06-02 | -4.57 |
| 2025-05-30 | -4.64 |
| 2025-05-29 | -4.71 |
| 2025-05-28 | -4.37 |
| 2025-05-27 | -4.21 |
| 2025-05-23 | -4.27 |
| 2025-05-22 | -4.33 |
| 2025-05-21 | -4.35 |
| 2025-05-20 | -4.41 |
| 2025-05-19 | -4.28 |
| 2025-05-16 | -4.22 |
| 2025-05-15 | -4.26 |
| 2025-05-14 | -4.06 |
| 2025-05-13 | -4.29 |
| 2025-05-12 | -4.18 |
| 2025-05-09 | -4.09 |
| 2025-05-08 | -4.09 |
| 2025-05-07 | -4.11 |
| 2025-05-06 | -4.20 |
| 2025-05-05 | -4.33 |
| 2025-05-02 | -4.43 |
| 2025-05-01 | -4.53 |
| 2025-04-30 | -4.64 |